Measurement of apolipoproteins A-i and A-Ii
Noma, A.; Kita, M.
Rinsho Byori. Japanese Journal of Clinical Pathology 31(7): 763-767
1983
ISSN/ISBN: 0047-1860 PMID: 6418934 Document Number: 210273
Document emailed within 1 workday
Related Documents
Tasaki, H. 2007: Measurement methods for apolipoproteins Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 205-209Marcovina, S.M.; Adolphson, J.L.; Parlavecchia, M.; Albers, J.J. 1990: Effects of lyophilization of serum on the measurement of apolipoproteins A-i and B Clinical Chemistry 36(2): 366-369
Banker, D.D. 1990: Apolipoproteins Indian Journal of Medical Sciences 44(10): 289
Arribas Castrillo, J.M. 1991: Apolipoproteins and atherosclerosis Anales de Medicina Interna 8(7): 317-319
Goswami, B. 2010: Apolipoproteins: emerging biomarkers for CAD Singapore Medical Journal 51(2): 179
Taniguchi, T.; Yamasaki, S. 1984: Apolipoproteins and atherosclerosis--study of apolipoprotein e Rinsho Byori. Japanese Journal of Clinical Pathology 32(7): 772-779
Beigl, Y.; Green, P.; Lurie, Y. 1987: Apolipoproteins and coronary heart disease Harefuah 112(8): 405-407
Luc, G.; Turpin, G.; De Gennes, J.L. 1983: Apolipoproteins. Structure, function and pathological changes Annales de Medecine Interne 134(8): 695-701
Koprovicová, J.; Kollár, J.; Rozdobudková, V. 1997: Levels of Lp(a) and apolipoproteins in vegetarians and their informative value in hyperlipidemia Bratislavske Lekarske Listy 98(1): 17-21
Weisweiler, P.; Schwandt, P. 1984: Determination of human apolipoproteins A-I, B, and E by laser nephelometry Journal of Clinical Chemistry and Clinical Biochemistry 22(1): 113-118
Nakai, T.; Oida, K. 1990: Quantification and clinical significance of plasma apolipoproteins Rinsho Byori. Japanese Journal of Clinical Pathology 38(2): 125-134
Pfalzer, B.; Hamm, H.; Beisiegel, U.; Ostendorf, P. 1992: Lipoproteins and apolipoproteins in human pleural effusions Journal of Laboratory and Clinical Medicine 120(3): 483-493
Sandkamp, M.; Tambyrajah, B.; Schriewer, H.; Assmann, G. 1988: Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method Journal of Clinical Chemistry and Clinical Biochemistry 26(11): 685-688
Mertz, D.P.; Göhmann, E.; Ostertag, J. 1981: Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk Die Medizinische Welt 32(43): 1611-1615
Person, B.; Leglise, D.; Bardou, L.G. 1985: On the need for establishing one's own reference values of apolipoproteins A1 and B in the detection of dyslipoproteinemia Presse Medicale 14(11): 642
Winkler, L.; Schlag, B.; Ostermann, G.; Dargel, R. 1989: Apolipoproteins as risk indicators of ischemic heart disease Przeglad Lekarski 46(7): 595-598
Liu, B.W.; Liang, J.S.; Fu, M.D. 1988: Serum lipids and apolipoproteins AI, B100, Ci and CIi in noninsulin-dependent diabetics Zhonghua Nei Ke Za Zhi 27(10): 627-629; 653-654
Osipov, S.G.; Keĭnova, E.E.; Titov, V.N.; Iaroshevskaia, F.M.; Eremeeva, M.V. 1986: Circulating immune complexes and apolipoproteins in ischemic heart disease Kardiologiia 26(4): 67-70
Panin, L.E.; Poteriaeva, O.N.; Atuchina, N.V.; Poliakov, L.M. 1998: Apolipoproteins A-I, B and E levels during intensive physical exertion and during recovery period Biulleten' Eksperimental'noi Biologii i Meditsiny 126(12): 615-617
de Arcos, F.; Castelo-Branco, C.; Casals, E.; Sanllehy, C.; Cararach, V. 1998: Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins Journal of Reproductive Medicine 43(2): 144-148